Relationship of T regulatory cells content, activity and serum autoantibodies level in patients with systemic lupus erythematosus receiving rituximab
Objective. To reveal changes of CD+CD25+FoxP3+ T-regulatory cells (T-reg) number in pts with systemic lupus erythematosus (SLE) receiving rituximab and to assess relationship T reg content with changes of disease activity and serum autoantibodies level during treatment. Material and methods. 12 pts...
Saved in:
Main Author: | A V Torgashina |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2009-04-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/590 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Use of rituximab in systemic lupus erythematosus in children: a review
by: A. N. Arefyeva
Published: (2019-11-01) -
Specific features of regulatory T cells in patients with systemic lupus erythematosus
by: A. V. Torgashina, et al.
Published: (2018-12-01) -
Experience in Rituximab Administration in Children with Systemic Lupus Erythematosus: a Retrospective Study of the Case Series
by: Mikhail M. Kostik, et al.
Published: (2016-08-01) -
Sequential therapy with rituximab and belimumab in patients with systemic lupus erythematosus
by: A. A. Mesnyankina, et al.
Published: (2020-11-01) -
Experience of Using Rituximab in a Girl with Severe Systemic Lupus Erythematosus
by: A. A. Lebedenko, et al.
Published: (2015-10-01)